142 related articles for article (PubMed ID: 2889222)
21. Differential effect of repeated treatment with L-dopa on dopamine-D1 or -D2 receptors.
Parenti M; Flauto C; Parati E; Vescovi A; Groppetti A
Neuropharmacology; 1986 Mar; 25(3):331-4. PubMed ID: 2871516
[TBL] [Abstract][Full Text] [Related]
22. Dissociation between the presynaptic dopamine-sensitive adenylate cyclase and [3H]spiperone binding sites in rat substantia nigra.
Quik M; Emson PC; Joyce E
Brain Res; 1979 May; 167(2):355-65. PubMed ID: 36204
[TBL] [Abstract][Full Text] [Related]
23. Evidence for different states of the dopamine D1 receptor: clozapine and fluperlapine may preferentially label an adenylate cyclase-coupled state of the D1 receptor.
Andersen PH; Braestrup C
J Neurochem; 1986 Dec; 47(6):1822-31. PubMed ID: 2945903
[TBL] [Abstract][Full Text] [Related]
24. Adenosine receptor-coupled adenylate cyclase in the caudate nucleus of the rat brain.
Moser A; Liebetrau A; Cramer H
Neuropharmacology; 1991 Jul; 30(7):769-73. PubMed ID: 1922688
[TBL] [Abstract][Full Text] [Related]
25. Pertussis toxin attenuates D2 inhibition and enhances D1 stimulation of adenylate cyclase by dopamine in rat striatum.
Olianas MC; Onali P
J Neurochem; 1987 May; 48(5):1443-7. PubMed ID: 2951497
[TBL] [Abstract][Full Text] [Related]
26. Differential modulation of D1 and D2 dopamine-sensitive adenylate cyclases by 17 beta-estradiol in cultured striatal neurons and anterior pituitary cells.
Maus M; Bertrand P; Drouva S; Rasolonjanahary R; Kordon C; Glowinski J; Premont J; Enjalbert A
J Neurochem; 1989 Feb; 52(2):410-8. PubMed ID: 2521359
[TBL] [Abstract][Full Text] [Related]
27. Muscarinic receptors modulate dopamine-activated adenylate cyclase of rat striatum.
Olianas MC; Onali P; Neff NH; Costa E
J Neurochem; 1983 Nov; 41(5):1364-9. PubMed ID: 6619871
[TBL] [Abstract][Full Text] [Related]
28. Topographical distribution of dopaminergic innervation and of dopaminergic receptors in the rat striatum. II. Distribution and characteristics of dopamine adenylate cyclase--interaction of d-LSD with dopaminergic receptors.
Bockaert J; Premont J; Glowinski J; Thierry AM; Tassin JP
Brain Res; 1976 May; 107(2):301-15. PubMed ID: 1268730
[TBL] [Abstract][Full Text] [Related]
29. The relationship between the occupation of the D-1 dopamine receptor by [3H]piflutixol and the activity of dopamine-sensitive adenylate cyclase in rat striatal membranes.
Fleminger S
Biochem Pharmacol; 1991 Jul; 42(2):229-37. PubMed ID: 1650205
[TBL] [Abstract][Full Text] [Related]
30. Aging process affects a single class of dopamine receptors.
Memo M; Lucchi L; Spano PF; Trabucchi M
Brain Res; 1980 Dec; 202(2):488-92. PubMed ID: 7437912
[TBL] [Abstract][Full Text] [Related]
31. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
Hungen KV; Roberts S; Hill DF
Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
[TBL] [Abstract][Full Text] [Related]
32. Inhibition of brain adenylate cyclase by A1 adenosine receptors: pharmacological characteristics and locations.
Ebersolt C; Premont J; Prochiantz A; Perez M; Bockaert J
Brain Res; 1983 May; 267(1):123-9. PubMed ID: 6305455
[TBL] [Abstract][Full Text] [Related]
33. Adenosine 3',5'-cyclic monophosphate as a possible mediator of rotational behaviour induced by dopaminergic receptor stimulation in rats lesioned unilaterally in the substantia nigra.
Satoh H; Satoh Y; Notsu Y; Honda F
Eur J Pharmacol; 1976 Oct; 39(2):365-77. PubMed ID: 185065
[TBL] [Abstract][Full Text] [Related]
34. Differential ontogeny of functional dopamine and muscarinic receptors mediating presynaptic inhibition of neurotransmitter release and postsynaptic regulation of adenylate cyclase activity in rat striatum.
De Vries TJ; Mulder AH; Schoffelmeer AN
Brain Res Dev Brain Res; 1992 Mar; 66(1):91-6. PubMed ID: 1350950
[TBL] [Abstract][Full Text] [Related]
35. Increased sensitivity in the interaction of the dopaminergic/adenosinergic system at the level of the adenylate cyclase activity in the striatum of the "weaver" mouse.
K B; V T; N P; M M; N M; F A
Neurochem Int; 2016 Oct; 99():233-238. PubMed ID: 27498335
[TBL] [Abstract][Full Text] [Related]
36. Chronic sulpiride treatment produces supersensitivity of striatal adenylate cyclase to dopamine in sexually immature or adult castrated rats.
Gnegy ME; Bernabei A; Treisman G
J Pharmacol Exp Ther; 1983 Mar; 224(3):627-33. PubMed ID: 6827485
[TBL] [Abstract][Full Text] [Related]
37. Single and repeated administration of neuroleptic drugs to rats: effects on striatal dopamine-sensitive adenylate cyclase and locomotor activity produced by tranylcypromine and L-tryptophan or L-Dopa.
Heal DJ; Green AR; Boullin DJ; Grahame-Smith DG
Psychopharmacology (Berl); 1976 Sep; 49(3):287-300. PubMed ID: 12527
[TBL] [Abstract][Full Text] [Related]
38. Nondopaminergic prefrontocortical efferent fibers modulate D1 receptor denervation supersensitivity in specific regions of the rat striatum.
Herve D; Trovero F; Blanc G; Thierry AM; Glowinski J; Tassin JP
J Neurosci; 1989 Nov; 9(11):3699-708. PubMed ID: 2479723
[TBL] [Abstract][Full Text] [Related]
39. Modulation by GTP of basal and agonist-stimulated striatal adenylate cyclase activity following chronic blockade of D1 and D2 dopamine receptors: involvement of G proteins in the development of receptor supersensitivity.
Schettini G; Ventra C; Florio T; Grimaldi M; Meucci O; Marino A
J Neurochem; 1992 Nov; 59(5):1667-74. PubMed ID: 1402912
[TBL] [Abstract][Full Text] [Related]
40. Is dopamine-induced inhibition of adenylate cyclase involved in the autoreceptor-mediated negative control of tyrosine hydroxylase in striatal dopaminergic terminals?
el Mestikawy S; Hamon M
J Neurochem; 1986 Nov; 47(5):1425-33. PubMed ID: 2876053
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
